Trials / Unknown
UnknownNCT04022031
Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,400 (estimated)
- Sponsor
- Tianjin University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- —
Summary
A prospective cohort study was performed in patients with angina pectoris who were treated with oral Chinese patent medicine and Western medicine.Collect primary and secondary efficacy indicators such as the incidence of cardiovascular events, using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of coronary heart disease with angina pectoris, and provide reliable data support for its clinical application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese patent medicine | Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2021-09-01
- Completion
- 2022-09-01
- First posted
- 2019-07-16
- Last updated
- 2019-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04022031. Inclusion in this directory is not an endorsement.